These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 27122212

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of salivary cortisol measurements for the diagnosis of subclinical Cushing's syndrome.
    Tateishi Y, Kouyama R, Mihara M, Doi M, Yoshimoto T, Hirata Y.
    Endocr J; 2012; 59(4):283-9. PubMed ID: 22261010
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome.
    Putignano P, Bertolini M, Losa M, Cavagnini F.
    J Endocrinol Invest; 2003 Jun; 26(6):539-44. PubMed ID: 12952368
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In the overnight dexamethasone suppression test, 1.0 mg loading is superior to 0.5 mg loading for diagnosing subclinical adrenal Cushing's syndrome based on plasma dexamethasone levels determined using liquid chromatography-tandem mass spectrometry.
    Sasaki Y, Katabami T, Asai S, Fukuda H, Tanaka Y.
    Endocr J; 2017 Sep 30; 64(9):833-842. PubMed ID: 28637948
    [Abstract] [Full Text] [Related]

  • 10. New diagnostic criteria of adrenal subclinical Cushing's syndrome: opinion from the Japan Endocrine Society.
    Yanase T, Oki Y, Katabami T, Otsuki M, Kageyama K, Tanaka T, Kawate H, Tanabe M, Doi M, Akehi Y, Ichijo T.
    Endocr J; 2018 Apr 26; 65(4):383-393. PubMed ID: 29576599
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism.
    Friedman TC.
    Exp Clin Endocrinol Diabetes; 2006 Jul 26; 114(7):356-60. PubMed ID: 16915537
    [Abstract] [Full Text] [Related]

  • 19. Overnight dexamethasone suppression test: comparison of plasma and salivary cortisol measurement for the screening of Cushing's syndrome.
    Barrou Z, Guiban D, Maroufi A, Fournier C, Dugué MA, Luton JP, Thomopoulos P.
    Eur J Endocrinol; 1996 Jan 26; 134(1):93-6. PubMed ID: 8590965
    [Abstract] [Full Text] [Related]

  • 20. Overnight dexamethasone suppression test in the diagnosis of Cushing's disease.
    Esfahanian F, Kazemi R.
    Acta Med Iran; 2010 Jan 26; 48(4):222-5. PubMed ID: 21279933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.